Beijing Konruns Pharmaceutical Co.,Ltd.

SHSE:603590 Stock Report

Market Cap: CN¥3.8b

Beijing Konruns PharmaceuticalLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure3.1yrs

Recent management updates

Recent updates

Beijing Konruns Pharmaceutical Co.,Ltd.'s (SHSE:603590) Shares Not Telling The Full Story

Sep 29
Beijing Konruns Pharmaceutical Co.,Ltd.'s (SHSE:603590) Shares Not Telling The Full Story

Concerns Surrounding Beijing Konruns PharmaceuticalLtd's (SHSE:603590) Performance

Sep 03
Concerns Surrounding Beijing Konruns PharmaceuticalLtd's (SHSE:603590) Performance

CEO

Beijing Konruns PharmaceuticalLtd has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Jianhua Liu
Chairman of the Board10.9yrsCN¥604.90k31.95%
CN¥ 1.2b
Xijuan Wang
Director10.9yrsno datano data
Xiaohan Liu
Director13.4yrsCN¥792.10kno data
Yonggong Zhai
Independent Director3.1yrsCN¥240.00kno data
Fang Fang
Supervisor3.1yrsno datano data
Ling Wang
Employee Representative Supervisor10.9yrsno datano data
Zhanqi Niu
President & Director1.3yrsCN¥3.27m0.22%
CN¥ 8.3m
Yun Zhou
Director2.5yrsno datano data
Jing Li
Director1.8yrsno datano data

3.1yrs

Average Tenure

57yo

Average Age

Experienced Board: 603590's board of directors are considered experienced (3.1 years average tenure).